急性呼吸窘迫综合症的体外膜肺氧合治疗研究新进展

Updated progress of ECMO in ARDS treatment

急性呼吸窘迫综合征(Acute Respiratory Distress Syndrome,ARDS)是一种肺内外严重疾病导致的以进行性呼吸窘迫和顽固性低氧血症为临床特征的综合征。虽然关于ARDS研究和机械通气技术不断进步,但ARDS患者的病死率仍高达40%,体外膜肺氧合(Extracorporeal Membrane Oxygenation,ECMO)可维持氧合、改善通气,起到“肺休息”的作用,目前广泛用于治疗ARDS疾病。本文主要就国内外应用ECMO治疗ARDS的新进展进行综述。

Acute Respiratory Distress Syndrome(ARDS)is a syndrome featured by progressive respiratory distress and refractory hypoxemia caused by severe diseases inside and outside the lung.Although studies on ARDS and mechanical ventilation technology have been advanced continuously,the mortality rate of ARDS patients remains as high as 40%.Being widely used in the treatment of ARDS,Extracorporeal Membrane Oxygenation(ECMO)can maintain oxygenation,improve ventilation,and contribute to“rest the lung”.This article reviewed the updated progress of ECMO in ARDS treatment at home and abroad.